BRK-B vs EMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
EMD exhibits strong value characteristics with a stable Piotroski F-Score of 6/9 and significant undervaluation relative to its Graham Number ($20.97) and Intrinsic Value ($51.33). The fund is trading at a low P/E of 6.17 and a Price/Book of 0.96, suggesting a deep discount to its underlying assets. While technical trends and insider sentiment are currently bearish, the combination of a 10.61% dividend yield and robust earnings growth (48.20%) provides a strong fundamental floor.
Compare Another Pair
Related Comparisons
BRK-B vs EMD: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Western Asset Emerging Markets Debt Fund Inc. (EMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.